Phase I PIANO trial—PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes

Authors: Sundar, R., Chia, D.K.A., Zhao, J.J., Lee, A.R.Y.B., Kim, G., Tan, H.L., Pang, A., Shabbir, A., Willaert, W., Ma, H., Huang, K.K., Hagihara, T., Tan, A.L.K., Ong, C.-A.J., Wong, J.S.M., Seo, C.J., Walsh, R., Chan, G., Cheo, S.W., Soh, C.C.C., Callebout, E., Geboes, K., Ng, M.C.H., Lum, J.H.Y., Leow, W.Q., Selvarajan, S., Hoorens, A., Ang, W.H., Pang, H., Tan, P., Yong, W.P., Chia, C.S.L., Ceelen, W., So, J.B.Y.

Source: In ESMO Open September 2024 9(9)

IDF23-0381 Improving Diabetic Wound Healing Outcomes with Topical Growth Factor Therapies: Systematic Review and Network Meta-Analysis of Randomised-controlled Trials

Authors: Wong, A.Y.W., Hooi, N.M.F., Yeo, B.S.Y., Sultana, R., Bee, Y.M., Lee, A.R.Y.B., Tay, S.M.

Source: In Diabetes Research and Clinical Practice March 2024 209 Supplement 1